
Auteur X. MAJO
|
Documents disponibles écrits par cet auteur (4)

C. FOLCH ; N. LORENTE ; X. MAJO ; O. PARES-BADELL ; X. ROCA ; T. BRUGAL ; P. ROUX ; P. CARRIERI ; J. COLOM ; J. CASABONA ; REDAN study group | 2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : PériodiqueBackground and aims: Despite the availability of several drug consumption rooms (DCR) in different European countries few epidemiological studies have evaluated their benefits. A network of DCR for people who inject drugs (PWID) has existed in C[...]
O. PARES-BADELL ; G. BARBAGLIA ; N. ROBINOWITZ ; X. MAJO ; M. TORRENS ; A. ESPELT ; M. BARTROLI ; M. GOTSENS ; M. T. BRUGAL | 2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : PériodiqueThe Barcelona model consists of offering harm reduction services - including drug consumption rooms (DCR) - hand-in-hand with substance use treatment programmes in care centres for substance use. The Barcelona model integrates different interven[...]
C. FOLCH ; V. SALUDES ; J. REYES-URENA ; A. ANTUORI ; N. IBANEZ ; X. MAJO ; J. COLOM ; L. MATAS ; J. CASABONA ; E. MARTRO | 2021
Dans International Journal of Drug Policy (Vol.90, April 2021) Article : PériodiqueBackground: This study aimed to describe the HCV cascade of care among people who inject drugs (PWID) in Catalonia, as well as to compare the observed gaps in care between Spanish-born and migrant PWID. Methods: A cross-sectional study of PWID [...]
O. PARES-BADELL ; A. ESPELT ; C. FOLCH ; X. MAJO ; V. GONZALEZ ; J. CASABONA ; M. T. BRUGAL | 2017
Dans Journal of Substance Abuse Treatment (Vol.77, June 2017) Article : PériodiqueBackground: The objective of this study was to estimate the proportion of undiagnosed HIV or Hepatitis C virus (HCV) infection and to assess the risk factors associated with an undiagnosed infection. Methods: A questionnaire was distributed amo[...]